Azenta (AZTA) Total Non-Current Liabilities (2010 - 2026)
Azenta's (AZTA) quarterly Total Non-Current Liabilities came in at $355.4 million in Q2 2026, up 5.56% year-over-year from $336.6 million in Q2 2025, and up 5.04% quarter-over-quarter from $338.3 million in Q1 2026.
Analysis
Azenta (AZTA) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Total Non-Current Liabilities for 17 consecutive years, with $355.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 5.56% year-over-year to $355.4 million in Q2 2026; TTM through Jun 2026 was $355.4 million, a 5.56% increase from a year earlier, with the FY2025 full-year figure at $348.1 million, changed N/A from the prior year.
- Total Non-Current Liabilities was $355.4 million for Q2 2026 at Azenta, up from $338.3 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $686.9 million in Q1 2022 and troughed at $288.3 million in Q2 2022.
- A 5-year average of $357.4 million and a median of $337.5 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities soared 81.55% in 2022 and tumbled 48.58% in 2023, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $402.5 million in 2022, then fell by 8.49% to $368.3 million in 2023, then fell by 14.65% to $314.4 million in 2024, then advanced by 10.74% to $348.1 million in 2025, then rose by 2.08% to $355.4 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $355.4 million (Q2 2026), $338.3 million (Q1 2026), and $348.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 55.95 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 33.25 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 6.06 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 3.52 Bn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 4.05 Bn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 457.16 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 2.88 Bn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 821.06 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 197.96 Mn |
| 10 | Azenta | 1.37 Bn | 1.04 Bn | 198.10 Mn | 355.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 355.36 Mn |
| Mar 31, 2026 | 338.32 Mn |
| Dec 31, 2025 | 348.13 Mn |
| Sep 30, 2025 | 321.45 Mn |
| Jun 30, 2025 | 336.64 Mn |
| Mar 31, 2025 | 328.50 Mn |
| Dec 31, 2024 | 314.37 Mn |
| Sep 30, 2024 | 323.15 Mn |
| Jun 30, 2024 | 321.31 Mn |
| Mar 31, 2024 | 329.02 Mn |
| Dec 31, 2023 | 368.33 Mn |
| Sep 30, 2023 | 339.05 Mn |
| Jun 30, 2023 | 333.15 Mn |
| Mar 31, 2023 | 353.19 Mn |
| Dec 31, 2022 | 402.53 Mn |
| Sep 30, 2022 | 346.01 Mn |
| Jun 30, 2022 | 288.31 Mn |
| Mar 31, 2022 | 686.91 Mn |
| Dec 31, 2021 | 483.14 Mn |
| Sep 30, 2021 | 488.01 Mn |